Research Article

Potential Clinical Value of 5-Hydroxytryptamine Receptor 3C as a Prognostic Biomarker for Lung Cancer

Table 2

Univariate and multivariate analysis of overall survival for lung cancer.

VariablesItemUnivariateMultivariate
HR95% CI valueHR95% CI value

Age (y)>701.62(0.79, 3.30)0.1882.37(0.98, 5.73)0.056
≤701.001.00

SexMale1.50(0.70, 3.21)0.2950.74(0.26, 2.11)0.576
Female1.001.00

GradeII/III1.82(0.70, 4.68)0.2181.05(0.33, 3.33)0.928
I1.001.00

T statusT4/T31.44(0.65, 3.18)0.3641.81(0.72, 4.52)0.205
T2/T11.001.00

N statusPositive3.43(1.64, 7.19)0.0013.26(1.42, 7.48)0.005
Negative1.001.00

M statusPositive3.35(1.59, 7.08)0.0021.24(0.42, 3.73)0.697
Negative1.001.00

HistologySquamous cell carcinoma2.72(1.36, 5.44)0.0053.98(1.59, 9.94)0.003
Adenocarcinoma1.001.00

Performance14.55(2.28, 9.07)<0.0015.34(2.24, 12.73)<0.001
01.001.00

Smoking statusCurrent2.54(1.19, 5.41)0.0161.71(0.56, 5.21)0.345
Former1.89(0.79, 4.52)0.1522.09(0.70, 6.26)0.187
Never1.001.00

HTR3CHigh5.69(2.20, 14.73)<0.0018.38(2.93, 23.98)<0.001
Low1.001.00

HR = hazard ratio; CI = confidence interval.